Literature DB >> 38070

A pharmacokinetic model for enterohepatic recirculation in the rat: phenolphthalein, a model drug.

W A Colburn, P C Hirom, R J Parker, P Milburn.   

Abstract

A classical compartmental pharmacokinetic model was developed to describe the systemic blood concentration-time profile of phenolphthalein and its glucuronide conjugate (total 3H) following a single intravenous bolus injection of [3H]phenolphthalein. The model incorporates a biliary transport system, including a finite lag time for the biliary phenophthalein glucuronide to be hydrolyzed in the intestine before absorption. Data obtained from bile duct-cannulated animals were fit to the same model excluding any component for intestinal absorption. Agreement between the rate constants obtained for both fits indicates that the model is internally consistent. The model was then used to simulate a 24-hour time-course of phenolphthalein-equivalent blood concentrations which indicates that the long apparent half-lives calculated during this period are artifacts of recirculation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 38070

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  9 in total

1.  In vivo-formed versus preformed metabolite kinetics of trans-resveratrol-3-sulfate and trans-resveratrol-3-glucuronide.

Authors:  Satish Sharan; Otito F Iwuchukwu; Daniel J Canney; Cheryl L Zimmerman; Swati Nagar
Journal:  Drug Metab Dispos       Date:  2012-07-17       Impact factor: 3.922

2.  Population Pharmacokinetic Modeling of the Enterohepatic Recirculation of Fimasartan in Rats, Dogs, and Humans.

Authors:  Tae Hwan Kim; Soyoung Shin; Cornelia B Landersdorfer; Yong Ha Chi; Soo Heui Paik; Jayhyuk Myung; Rajbharan Yadav; Stefan Horkovics-Kovats; Jürgen B Bulitta; Beom Soo Shin
Journal:  AAPS J       Date:  2015-05-20       Impact factor: 4.009

3.  Mean residence time for drugs subject to enterohepatic cycling.

Authors:  T A Shepard; G F Lockwood; L J Aarons; I D Abrahams
Journal:  J Pharmacokinet Biopharm       Date:  1989-06

4.  Estimation of area under the curve for drugs subject to enterohepatic cycling.

Authors:  T A Shepard; R H Reuning; L J Aarons
Journal:  J Pharmacokinet Biopharm       Date:  1985-12

5.  Estimating the fraction reabsorbed in drugs undergoing enterohepatic circulation.

Authors:  F L Tse; F Ballard; J Skinn
Journal:  J Pharmacokinet Biopharm       Date:  1982-08

6.  Estrogenic effects of phenolphthalein on human breast cancer cells in vitro.

Authors:  P M Ravdin; M van Beurden; V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

7.  Assessment of enterohepatic circulation of radioactivity following a single dose of [14C]nimodipine in the rat.

Authors:  D Suwelack; H Weber
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1985 Jul-Sep       Impact factor: 2.441

8.  The pharmacokinetics of penicillamine in a female mongrel dog.

Authors:  R F Bergstrom; R D Kay; J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1981-10

9.  A recirculatory model with enterohepatic circulation by measuring portal and systemic blood concentration difference.

Authors:  Toshiya Moriwaki; Hiroyuki Yasui; Akira Yamamoto
Journal:  J Pharmacokinet Pharmacodyn       Date:  2003-04       Impact factor: 2.745

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.